These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 26892465)

  • 21. Rapamycin-induced autophagy plays a pro-survival role by enhancing up-regulation of intracellular ferritin expression in acute lymphoblastic leukemia.
    Gong Y; Wu J; Yang R; Zhang L; Ma Z
    Exp Oncol; 2020 Mar; 42(1):11-15. PubMed ID: 32231197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential.
    Neri LM; Cani A; Martelli AM; Simioni C; Junghanss C; Tabellini G; Ricci F; Tazzari PL; Pagliaro P; McCubrey JA; Capitani S
    Leukemia; 2014 Apr; 28(4):739-48. PubMed ID: 23892718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical in vivo evaluation of rapamycin in human malignant peripheral nerve sheath explant xenograft.
    Bhola P; Banerjee S; Mukherjee J; Balasubramanium A; Arun V; Karim Z; Burrell K; Croul S; Gutmann DH; Guha A
    Int J Cancer; 2010 Jan; 126(2):563-71. PubMed ID: 19634141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mammalian target of rapamycin inhibitor RAD001 (everolimus) synergizes with chemotherapeutic agents, ionizing radiation and proteasome inhibitors in pre-B acute lymphocytic leukemia.
    Saunders P; Cisterne A; Weiss J; Bradstock KF; Bendall LJ
    Haematologica; 2011 Jan; 96(1):69-77. PubMed ID: 20952516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL).
    Gazi M; Moharram SA; Marhäll A; Kazi JU
    Cancer Lett; 2017 Apr; 392():9-16. PubMed ID: 28159681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FAK mediates the activation of cardiac fibroblasts induced by mechanical stress through regulation of the mTOR complex.
    Dalla Costa AP; Clemente CF; Carvalho HF; Carvalheira JB; Nadruz W; Franchini KG
    Cardiovasc Res; 2010 Jun; 86(3):421-31. PubMed ID: 20038548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor.
    Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG
    Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibiting the mTOR pathway synergistically enhances cytotoxicity in ovarian cancer cells induced by etoposide through upregulation of c-Jun.
    Itamochi H; Oishi T; Shimada M; Sato S; Uegaki K; Naniwa J; Sato S; Nonaka M; Terakawa N; Kigawa J; Harada T
    Clin Cancer Res; 2011 Jul; 17(14):4742-50. PubMed ID: 21610153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapamycin restores p14, p15 and p57 expression and inhibits the mTOR/p70S6K pathway in acute lymphoblastic leukemia cells.
    Li H; Kong X; Cui G; Ren C; Fan S; Sun L; Zhang Y; Cao R; Li Y; Zhou J
    Int J Hematol; 2015 Nov; 102(5):558-68. PubMed ID: 26362858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models.
    Pignochino Y; Dell'Aglio C; Basiricò M; Capozzi F; Soster M; Marchiò S; Bruno S; Gammaitoni L; Sangiolo D; Torchiaro E; D'Ambrosio L; Fagioli F; Ferrari S; Alberghini M; Picci P; Aglietta M; Grignani G
    Clin Cancer Res; 2013 Apr; 19(8):2117-31. PubMed ID: 23434734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. mTOR kinase inhibitors synergize with histone deacetylase inhibitors to kill B-cell acute lymphoblastic leukemia cells.
    Beagle BR; Nguyen DM; Mallya S; Tang SS; Lu M; Zeng Z; Konopleva M; Vo TT; Fruman DA
    Oncotarget; 2015 Feb; 6(4):2088-100. PubMed ID: 25576920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapamycin regulates the proliferation of Huh7, a hepatocellular carcinoma cell line, by up-regulating p53 expression.
    Kwon S; Jeon JS; Ahn C; Sung JS; Choi I
    Biochem Biophys Res Commun; 2016 Oct; 479(1):74-9. PubMed ID: 27616194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth inhibition and suppression of the mTOR and Wnt/β-catenin pathways in T-acute lymphoblastic leukemia by rapamycin and MYCN depletion.
    Kong D; Fan S; Sun L; Chen X; Zhao Y; Zhao L; Guo Z; Li Y
    Hematol Oncol; 2021 Apr; 39(2):222-230. PubMed ID: 33300153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Essential role for cyclic-AMP responsive element binding protein 1 (CREB) in the survival of acute lymphoblastic leukemia.
    van der Sligte NE; Kampen KR; ter Elst A; Scherpen FJ; Meeuwsen-de Boer TG; Guryev V; van Leeuwen FN; Kornblau SM; de Bont ES
    Oncotarget; 2015 Jun; 6(17):14970-81. PubMed ID: 26008971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulating CREBBP inhibits proliferation and cell cycle progression and induces daunorubicin resistance in leukemia cells.
    Gao C; Liu SG; Lu WT; Yue ZX; Zhao XX; Xing TY; Chen ZP; Zheng HY; Li ZG
    Mol Med Rep; 2020 Oct; 22(4):2905-2915. PubMed ID: 32945392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idarubicin induces mTOR-dependent cytotoxic autophagy in leukemic cells.
    Ristic B; Bosnjak M; Arsikin K; Mircic A; Suzin-Zivkovic V; Bogdanovic A; Perovic V; Martinovic T; Kravic-Stevovic T; Bumbasirevic V; Trajkovic V; Harhaji-Trajkovic L
    Exp Cell Res; 2014 Aug; 326(1):90-102. PubMed ID: 24907655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dual kinase inhibitor NVP-BEZ235 in combination with cytotoxic drugs exerts anti-proliferative activity towards acute lymphoblastic leukemia cells.
    Schult C; Dahlhaus M; Glass A; Fischer K; Lange S; Freund M; Junghanss C
    Anticancer Res; 2012 Feb; 32(2):463-74. PubMed ID: 22287733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the miR-150 tumor suppressor is restored by and synergizes with rapamycin in a human leukemia T-cell line.
    Podshivalova K; Wang EA; Hart T; Salomon DR
    Leuk Res; 2018 Nov; 74():1-9. PubMed ID: 30269036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulation.
    Cheng YJ; Zhu ZX; Zhou JS; Hu ZQ; Zhang JP; Cai QP; Wang LH
    World J Gastroenterol; 2015 Feb; 21(8):2323-35. PubMed ID: 25741138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.